Baidu
map

付费视频医生咨询服务商Doctor on Demand获300万美元投资

2013-12-23 MedSci MedSci原创

医生咨询服务Doctor on Demand刚上线,并宣布完成了300万美元种子期融资,投资方包括Venrock、A16Z和GoogleVentures。 用户使用Doctor on Demand可以对自己的病症找大夫进行付费咨询,是ondemand形式,通过视频或网络电话直接联系到大夫,在沟通前用户也可先描述病症并上传相关医 学影像。每通咨询是40美元。Doctor on Demand说

医生咨询服务Doctor on Demand刚上线,并宣布完成了300万美元种子期融资,投资方包括Venrock、A16Z和GoogleVentures。

用户使用Doctor on Demand可以对自己的病症找大夫进行付费咨询,是ondemand形式,通过视频或网络电话直接联系到大夫,在沟通前用户也可先描述病症并上传相关医 学影像。每通咨询是40美元。Doctor on Demand说他们平台有1千名认证美国医师。国内的春雨医生早在去年4月已经有了付费电话咨询服务。

未来很可能我们的医疗方式都会改变。日常可穿戴设备持续记录我们的身体数据(如心率),可用作医生诊疗时的参考。诸如验尿之类的医学检测也会变得平民化,很可能这些常规检测在家里就能完成了。类23andMe等基因检测会让人们自出生起就能注意某类高风险疾病。

评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1858301, encodeId=22741858301cd, content=<a href='/topic/show?id=21311323521' target=_blank style='color:#2F92EE;'>#OCT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13235, encryptionId=21311323521, topicName=OCT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Wed Sep 24 03:36:00 CST 2014, time=2014-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1862739, encodeId=6bd91862e394b, content=<a href='/topic/show?id=0b69542242' target=_blank style='color:#2F92EE;'>#CTO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5422, encryptionId=0b69542242, topicName=CTO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c66088, createdName=gao_jian4217, createdTime=Thu Oct 30 13:36:00 CST 2014, time=2014-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317211, encodeId=bc1f131e21163, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6704, encryptionId=74916e0414, topicName=EMA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Wed Dec 25 08:36:00 CST 2013, time=2013-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548244, encodeId=deeb15482447c, content=<a href='/topic/show?id=e29a2536eb2' target=_blank style='color:#2F92EE;'>#付费#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25367, encryptionId=e29a2536eb2, topicName=付费)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d71414069159, createdName=ms4657536712156177, createdTime=Wed Dec 25 08:36:00 CST 2013, time=2013-12-25, status=1, ipAttribution=)]
    2014-09-24 habb
  2. [GetPortalCommentsPageByObjectIdResponse(id=1858301, encodeId=22741858301cd, content=<a href='/topic/show?id=21311323521' target=_blank style='color:#2F92EE;'>#OCT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13235, encryptionId=21311323521, topicName=OCT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Wed Sep 24 03:36:00 CST 2014, time=2014-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1862739, encodeId=6bd91862e394b, content=<a href='/topic/show?id=0b69542242' target=_blank style='color:#2F92EE;'>#CTO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5422, encryptionId=0b69542242, topicName=CTO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c66088, createdName=gao_jian4217, createdTime=Thu Oct 30 13:36:00 CST 2014, time=2014-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317211, encodeId=bc1f131e21163, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6704, encryptionId=74916e0414, topicName=EMA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Wed Dec 25 08:36:00 CST 2013, time=2013-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548244, encodeId=deeb15482447c, content=<a href='/topic/show?id=e29a2536eb2' target=_blank style='color:#2F92EE;'>#付费#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25367, encryptionId=e29a2536eb2, topicName=付费)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d71414069159, createdName=ms4657536712156177, createdTime=Wed Dec 25 08:36:00 CST 2013, time=2013-12-25, status=1, ipAttribution=)]
    2014-10-30 gao_jian4217
  3. [GetPortalCommentsPageByObjectIdResponse(id=1858301, encodeId=22741858301cd, content=<a href='/topic/show?id=21311323521' target=_blank style='color:#2F92EE;'>#OCT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13235, encryptionId=21311323521, topicName=OCT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Wed Sep 24 03:36:00 CST 2014, time=2014-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1862739, encodeId=6bd91862e394b, content=<a href='/topic/show?id=0b69542242' target=_blank style='color:#2F92EE;'>#CTO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5422, encryptionId=0b69542242, topicName=CTO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c66088, createdName=gao_jian4217, createdTime=Thu Oct 30 13:36:00 CST 2014, time=2014-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317211, encodeId=bc1f131e21163, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6704, encryptionId=74916e0414, topicName=EMA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Wed Dec 25 08:36:00 CST 2013, time=2013-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548244, encodeId=deeb15482447c, content=<a href='/topic/show?id=e29a2536eb2' target=_blank style='color:#2F92EE;'>#付费#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25367, encryptionId=e29a2536eb2, topicName=付费)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d71414069159, createdName=ms4657536712156177, createdTime=Wed Dec 25 08:36:00 CST 2013, time=2013-12-25, status=1, ipAttribution=)]
    2013-12-25 fengyi812
  4. [GetPortalCommentsPageByObjectIdResponse(id=1858301, encodeId=22741858301cd, content=<a href='/topic/show?id=21311323521' target=_blank style='color:#2F92EE;'>#OCT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13235, encryptionId=21311323521, topicName=OCT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Wed Sep 24 03:36:00 CST 2014, time=2014-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1862739, encodeId=6bd91862e394b, content=<a href='/topic/show?id=0b69542242' target=_blank style='color:#2F92EE;'>#CTO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5422, encryptionId=0b69542242, topicName=CTO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c66088, createdName=gao_jian4217, createdTime=Thu Oct 30 13:36:00 CST 2014, time=2014-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317211, encodeId=bc1f131e21163, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6704, encryptionId=74916e0414, topicName=EMA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Wed Dec 25 08:36:00 CST 2013, time=2013-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548244, encodeId=deeb15482447c, content=<a href='/topic/show?id=e29a2536eb2' target=_blank style='color:#2F92EE;'>#付费#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25367, encryptionId=e29a2536eb2, topicName=付费)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d71414069159, createdName=ms4657536712156177, createdTime=Wed Dec 25 08:36:00 CST 2013, time=2013-12-25, status=1, ipAttribution=)]

相关资讯

Google投资生物医药公司大盘点

近日,Google旗下风险投资机构谷歌风投(Google Ventures)公布了2013年“成绩单”。本年度谷歌风投进行了75次新投资,成功从10个项目中退出,退出包括IPO以及并购。其中,成功IPO 的公司有Silver Spring Networks,RetailMeNot,Foundation Medicine;被其他巨头收购的公司有Parse(被Facebook收购),

十大外资制药公司在中国的投资排名

由于其他国家医药市场看起来长期低迷,大型医药公司正在将赌注押在中国这个新兴市场。而且中国市场使得其他新兴的机会看起来无足轻重。据Datamonitor预测,中国的糖尿病市场2019年将达到21亿美元。这份巨大的市场蛋糕吸引了小部分大型制药公司的眼球,它们正极力争取控制这个市场。 赛诺菲、礼来、默克都是这场竞争的挑战者。每家公司都在花大代价蚕食本由诺和诺德和拜耳公司占有的市场。在这个竞争激烈、高风

Baidu
map
Baidu
map
Baidu
map